BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jose A, Ninave KM, Karnam S, Venuganti VVK. Temperature-sensitive liposomes for co-delivery of tamoxifen and imatinib for synergistic breast cancer treatment. J Liposome Res 2019;29:153-62. [PMID: 30022700 DOI: 10.1080/08982104.2018.1502315] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Day CM, Hickey SM, Song Y, Plush SE, Garg S. Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles. Molecules. 2020;25. [PMID: 32151063 DOI: 10.3390/molecules25051182] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
2 Rolle F, Bincoletto V, Gazzano E, Rolando B, Lollo G, Stella B, Riganti C, Arpicco S. Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells. International Journal of Pharmaceutics 2020;580:119191. [DOI: 10.1016/j.ijpharm.2020.119191] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
3 Yang B, Song BP, Shankar S, Guller A, Deng W. Recent advances in liposome formulations for breast cancer therapeutics. Cell Mol Life Sci 2021;78:5225-43. [PMID: 33974093 DOI: 10.1007/s00018-021-03850-6] [Reference Citation Analysis]
4 Chao X, Zhao L, Ma N, Mou Y, Zhang P. Nanotechnology-based drug delivery systems for the improved sensitization of tamoxifen. Journal of Drug Delivery Science and Technology 2021;61:102229. [DOI: 10.1016/j.jddst.2020.102229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Castañeda-Reyes ED, Perea-Flores MJ, Davila-Ortiz G, Lee Y, Gonzalez de Mejia E. Development, Characterization and Use of Liposomes as Amphipathic Transporters of Bioactive Compounds for Melanoma Treatment and Reduction of Skin Inflammation: A Review. Int J Nanomedicine 2020;15:7627-50. [PMID: 33116492 DOI: 10.2147/IJN.S263516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Mangla B, Neupane YR, Singh A, Kumar P, Shafi S, Kohli K. Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane: ex vivo , in vivo and toxicity studies. Nanomedicine 2020;15:2563-83. [DOI: 10.2217/nnm-2020-0277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Zeinali M, Abbaspour-ravasjani S, Ghorbani M, Babazadeh A, Soltanfam T, Santos AC, Hamishehkar H, Hamblin MR. Nanovehicles for co-delivery of anticancer agents. Drug Discovery Today 2020;25:1416-30. [DOI: 10.1016/j.drudis.2020.06.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
8 Foroughi-Nia B, Barar J, Memar MY, Aghanejad A, Davaran S. Progresses in polymeric nanoparticles for delivery of tyrosine kinase inhibitors. Life Sci 2021;278:119642. [PMID: 34033837 DOI: 10.1016/j.lfs.2021.119642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Maia ALC, e Silva AT, César AL, Giuberti CS, Evangelista FC, Lemos JDA, Sabino AP, Malachias Â, Fernandes C, de Barros AL, Soares DC, Ramaldes GA. Preparation and characterization of gadolinium-based thermosensitive liposomes: A potential nanosystem for selective drug delivery to cancer cells. Journal of Drug Delivery Science and Technology 2021;65:102686. [DOI: 10.1016/j.jddst.2021.102686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Refaat A, Del Rosal B, Palasubramaniam J, Pietersz G, Wang X, Moulton SE, Peter K. Near-infrared light-responsive liposomes for protein delivery: Towards bleeding-free photothermally-assisted thrombolysis. J Control Release 2021;337:212-23. [PMID: 34284049 DOI: 10.1016/j.jconrel.2021.07.024] [Reference Citation Analysis]
11 Ruiz-Pulido G, Medina DI, Barani M, Rahdar A, Sargazi G, Baino F, Pandey S. Nanomaterials for the Diagnosis and Treatment of Head and Neck Cancers: A Review. Materials (Basel) 2021;14:3706. [PMID: 34279276 DOI: 10.3390/ma14133706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Sato W, Zajkowski T, Moser F, Adamala KP. Synthetic cells in biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1761. [PMID: 34725945 DOI: 10.1002/wnan.1761] [Reference Citation Analysis]
13 Wang Y, Minden A. The Use of Nanomedicine to Target Signaling by the PAK Kinases for Disease Treatment. Cells 2021;10:3565. [PMID: 34944073 DOI: 10.3390/cells10123565] [Reference Citation Analysis]
14 Navya PN, Kaphle A, Srinivas SP, Bhargava SK, Rotello VM, Daima HK. Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Converg 2019;6:23. [PMID: 31304563 DOI: 10.1186/s40580-019-0193-2] [Cited by in Crossref: 149] [Cited by in F6Publishing: 100] [Article Influence: 49.7] [Reference Citation Analysis]
15 Wang J, Zhu M, Nie G. Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles. Adv Drug Deliv Rev 2021;178:113974. [PMID: 34530015 DOI: 10.1016/j.addr.2021.113974] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
16 Li L, Fu J, Wang X, Chen Q, Zhang W, Cao Y, Ran H. Biomimetic "Nanoplatelets" as a Targeted Drug Delivery Platform for Breast Cancer Theranostics. ACS Appl Mater Interfaces 2021;13:3605-21. [PMID: 33449625 DOI: 10.1021/acsami.0c19259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Wang J, Gong J, Wei Z. Strategies for Liposome Drug Delivery Systems to Improve Tumor Treatment Efficacy. AAPS PharmSciTech 2021;23:27. [PMID: 34907483 DOI: 10.1208/s12249-021-02179-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Dimitriou P, Li J, Tornillo G, McCloy T, Barrow D. Droplet Microfluidics for Tumor Drug-Related Studies and Programmable Artificial Cells. Glob Chall 2021;5:2000123. [PMID: 34267927 DOI: 10.1002/gch2.202000123] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Li Y, Yang B, Zhang X. Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption. Int J Pharm 2019;568:118508. [PMID: 31299337 DOI: 10.1016/j.ijpharm.2019.118508] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
20 Gote V, Nookala AR, Bolla PK, Pal D. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. Int J Mol Sci 2021;22:4673. [PMID: 33925129 DOI: 10.3390/ijms22094673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]